Sex Hormone Binding Globulin as a Predictor of <i>in Vitro</i> Fertilization Outcomes in Polycystic Ovary Syndrome: Our Results

Abstract

Objectives: in case of Polycystic Ovary Syndrome (SOPK), predicting ovarian response before undertaking risky in vitro fertilization (IVF) proceeds is crucial. Sex Hormone Binding Globulin (SHBG) is introduced in literature as an interesting indicator of follicle's maturation and quality. The aim of this study was to investigate whether serum SHBG levels are related to fertilization outcomes in SOPK women undergoing IVF procedures. Methods: in a prospective cohort study, we enrolled 61 SOPK women and 91 matched group of infertile women. All of them were undergoing FIV/ICSI proceeds. SHBG levels were performed in peripheral blood samples as well as others hormones determination. Results: we noted significant differences between our study group of SOPK patients and the Control group concerning the characteristics of the ovarian response to gonadotrophins administration and concerning the profile of biological proceeds' outcomes. But no significant correlation between SHBG and FIV/ICSI outcomes was found either in SOPK or in Control group. Conclusions: our study provides evidence that SHBG can't be considered as a predictor of IVF outcomes because production of this steroid-binding protein depends on many parameters such as metabolic disorders frequently associated with SOPK.

Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis

“…To our best knowledge, this is the first systematic review and meta-analysis of studies showing the potential Subtotal (I-squared = 0.0%, p = 0.848) Skrgatic L et al, 2012Joshi B et al, 2016Houjeghani S 2012Lauritsen MP et al, 2014Liu Q et al, 2008Song DK et al, 2014Meriem G et al, 2016Dikmen E et al, 2011 Subtotal (I-squared = 93.6%, p = 0.000) Pangaribuan B et al, 2012Baldani DP et al, 2015Schweighofer N et al, 2012Zhu Q et al, 2016 Case-control Study Anttila L et al, 1996Bendlov B et al, 2007Zhang Y et al, 2006ID Jamil AS et al, 2015 Cohort Study Koiou E et al, 2011Jayagopal et al, 2003Tarkun I et al, 2004El-Shal AS et al, 2013Abu HTM et al, 2016Alili A et al, 2014Chae SJ et al, 2010Prelevit GM et al, 1993 Subtotal (I-squared = 94.8%, p = 0.000) Ferk P et al, 2006Seiminska L et al, 2004Legro RS et al, 2002Tarkun S et al, 2010Atamer A et al, 2008Dadachanji R et al, 2015N. Xita et al, 2008Schüring AN et al, 2012Yasmin E et al, 2012 Cross-sectional Kim JW et al, 2012Kandasamy S et al, 2016Garcia MA et al, 2012Oh JY et al, 2009 -0.83 (-1.01, -0.64) endocrine abnormalities has been extensively studied.…”